Immunology (24 companies · 17 conditions)

Conditions

Rheumatoid Arthritis 8 Systemic Lupus Erythematosus 8 Chronic Urticaria 4 Idiopathic Inflammatory Myopathies 4 Rare Sjögren's Syndrome 4 Systemic Sclerosis 4 Rare Ulcerative Colitis 3 Psoriatic Arthritis 2 ANCA-Associated Vasculitis 1 Rare Axial Spondyloarthritis 1 Cow's Milk Allergy 1 Crohn's Disease 1 Dermatomyositis 1 Rare Graves' Disease 1 Hereditary Angioedema 1 Rare Leukocyte Adhesion Deficiency-I 1 Rare Peanut Allergy 1

Companies

Ticker	Company	Therapeutic areas	In Immunology	Lead stage	Programs
ALLO	Allogene Therapeutics, Inc.	ImmunologyOncology Rare	3	Phase 2	12
ANAB	ANAPTYSBIO, INC	DermatologyGI/HepatologyImmunologyOncology Rare	1	Approved	6
RCUS	Arcus Biosciences, Inc.	DermatologyImmunologyOncology	1	Phase 3	7
ARTV	Artiva Biotherapeutics, Inc.	DermatologyImmunologyOncologyRenal Rare	6	Phase 2	16
CABA	Cabaletta Bio, Inc.	DermatologyImmunologyNeurologyRenal Rare	4	Phase 1	8
CRBU	Caribou Biosciences, Inc.	ImmunologyOncology	0	Phase 3	4
CLDX	Celldex Therapeutics, Inc.	DermatologyGI/HepatologyImmunologyRespiratory	3	Phase 3	7
IPSC	Century Therapeutics, Inc.	ImmunologyMetabolicRenal Rare	6	Phase 1	11
CLYM	Climb Bio, Inc.	HematologyImmunologyRenal Rare	2	Phase 2	7
CGEM	Cullinan Therapeutics, Inc.	ImmunologyOncology	4	NDA Submitted	7
DBVT	DBV Technologies S.A.	GI/HepatologyImmunology Rare	2	NDA Submitted	3
ENTA	ENANTA PHARMACEUTICALS INC	DermatologyImmunologyInfectious Disease	1	Phase 2	6
EVMN	Evommune, Inc.	DermatologyImmunologyNeurology	3	Phase 2	6
IMVT	Immunovant, Inc.	ImmunologyNeurology Rare	4	Phase 2	6
INAB	IN8BIO, INC.	ImmunologyOncology	1	Phase 2	6
IXHL	Incannex Healthcare Inc.	ImmunologyNeurologyRespiratory	1	Phase 2	3
NTLA	Intellia Therapeutics, Inc.	CardiovascularImmunology Rare	1	NDA Submitted	5
JBIO	Jade Biosciences, Inc.	ImmunologyRenal Rare	1	Phase 1	5
KYTX	Kyverna Therapeutics, Inc.	ImmunologyNeurologyRenal Rare	1	NDA Submitted	7
ORKA	Oruka Therapeutics, Inc.	DermatologyImmunology Rare	1	Phase 2	6
RCKT	ROCKET PHARMACEUTICALS, INC.	CardiovascularHematologyImmunology Rare	1	Approved	4
SYRE	Spyre Therapeutics, Inc.	Immunology	12	Phase 2	12
VNDA	Vanda Pharmaceuticals Inc.	CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare	1	Approved	26
VOR	Vor Biopharma Inc.	ImmunologyNeurologyOncology Rare	1	Phase 3	4